GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » Change In Receivables

Sci Pharmtech (TPE:4119) Change In Receivables : NT$1 Mil (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech Change In Receivables?

Sci Pharmtech's change in receivables for the quarter that ended in Mar. 2024 was NT$54 Mil. It means Sci Pharmtech's Accounts Receivable declined by NT$54 Mil from Dec. 2023 to Mar. 2024 .

Sci Pharmtech's change in receivables for the fiscal year that ended in Dec. 2023 was NT$-134 Mil. It means Sci Pharmtech's Accounts Receivable increased by NT$134 Mil from Dec. 2022 to Dec. 2023 .

Sci Pharmtech's Accounts Receivable for the quarter that ended in Mar. 2024 was NT$253 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sci Pharmtech's Days Sales Outstanding for the three months ended in Mar. 2024 was 74.51.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sci Pharmtech's liquidation value for the three months ended in Mar. 2024 was NT$-72 Mil.


Sci Pharmtech Change In Receivables Historical Data

The historical data trend for Sci Pharmtech's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech Change In Receivables Chart

Sci Pharmtech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.51 15.83 254.77 -90.59 -133.80

Sci Pharmtech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -80.97 -31.56 7.35 -28.62 54.34

Sci Pharmtech Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sci Pharmtech  (TPE:4119) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sci Pharmtech's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=253.031/309.879*91
=74.51

2. In Ben Graham's calculation of liquidation value, Sci Pharmtech's accounts receivable are only considered to be worth 75% of book value:

Sci Pharmtech's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=994.362-1556.96+0.75 * 253.031+0.5 * 601.181
=-72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sci Pharmtech Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sci Pharmtech's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Sci Pharmtech (TPE:4119) Business Description

Traded in Other Exchanges
N/A
Address
No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Sci Pharmtech Inc is engaged in research and development, manufacture and sale of active pharmaceutical ingredients, intermediates, specialty chemicals. Geographically, the primary markets of company are Italy, Germany, Japan, Taiwan, United states, China, Switzerland, Spain and others.

Sci Pharmtech (TPE:4119) Headlines

No Headlines